We use cookies to offer you an optimal experience on our website. By browsing our website, you accept the use of cookies.

You must be logged in to watch this video. Click here to access your account, or here to register for free!

Duodenal mucosal resurfacing: a new procedural therapy for type 2 diabetes: safety and proof of principle, first in human clinical study

Epublication WebSurg.com, May 2015;15(05). URL: http://websurg.com/doi/lt03engalvaoneto008

Ask a question to the author

You must be logged in to ask a question to authors. Click here to access your account, or here to register for free!
  • 346
  • 8
  • 2015-05-07
Share it
Bariatric surgery has emerged as a highly effective treatment for obesity and is increasingly recognized to have benefits for glycemic management in patients with pre-existing type 2 diabetes mellitus (T2DM). Understanding the efficacy and physiological effects of bariatric surgery on metabolism will push forward a novel approach to interventional procedures for diabetes treatment. In this key lecture, Dr. Galvao Neto presents the first result of a novel endoscopic approach to type 2 diabetes, namely duodenal mucosal resurfacing.